• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].

作者信息

Carreño García V, Hernández-Guío C, Bartolomé Nebreda J, Quiroga Estévez J A

机构信息

Departamento de Gastroenterología, Unidad de Hepatología, Fundación Jiménez Diaz, Madrid.

出版信息

Rev Esp Enferm Dig. 1993 Mar;83(3):169-75.

PMID:7683894
Abstract

We have investigated the relation between acute-like transaminase exacerbations and the induction of 2',5'-oligoadenylate (2-5A) synthetase activity, HLA-I associated beta 2-microglobulin and macrophage activated release of neopterin during hepatitis B virus clearance in 70 patients treated or not with interferon. In treated patients who had an exacerbation in ALT during HBV clearance (loss of HBeAg and HBV-DNA from serum), the activity of the enzyme 2-5A synthetase and the level of beta 2 microglobulin increased markedly (p < 0.05). In contrast, in the absence of a peak in ALT during HBV clearance following interferon administration, the levels of 2-5A synthetase activity and neopterin, but not of beta 2-microglobulin, rose significantly (p < 0.05). Neither the non-responder treated patients nor the untreated controls had significant changes in these parameters, irrespective of the transaminase levels. Thus, elimination of viremia after interferon treatment may occur by different pathways as reflected by the presence or absence of acute-like biochemical exacerbations.

摘要

相似文献

1
[Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].
Rev Esp Enferm Dig. 1993 Mar;83(3):169-75.
2
Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
Res Commun Chem Pathol Pharmacol. 1994 Mar;83(3):303-16.
3
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
AIDS. 1991 Mar;5(3):289-93. doi: 10.1097/00002030-199103000-00007.
4
[Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):981-5.
5
Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.慢性乙型肝炎患者天然人白细胞介素-2的初步研究。免疫调节和抗病毒作用。
J Hepatol. 1993 Sep;19(2):259-67. doi: 10.1016/s0168-8278(05)80580-x.
6
Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.非甲非乙型和乙型慢性肝炎患者对干扰素治疗的临床、组织学及免疫学反应的对比研究
Am J Gastroenterol. 1990 Jan;85(1):24-9.
7
Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.慢性乙型肝炎急性加重期外周血单个核细胞和血清中2',5'-寡腺苷酸合成酶活性升高。
Hepatology. 1989 May;9(5):715-9. doi: 10.1002/hep.1840090510.
8
Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.在无可测血清浓度情况下干扰素对人体生物反应的调节作用:皮下注射与静脉注射β-丝氨酸干扰素的对比试验
J Natl Cancer Inst. 1989 Jul 19;81(14):1061-8. doi: 10.1093/jnci/81.14.1061.
9
Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.β干扰素和γ干扰素联合进行5天持续输注的生物学及临床效应
Cancer Res. 1990 Aug 1;50(15):4588-94.
10
Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma.
J Interferon Cytokine Res. 1996 Oct;16(10):777-81. doi: 10.1089/jir.1996.16.777.